Pfizer asks FDA to allow COVID vaccine shots for children ages 5 to 11


Pfizer requested the U.S. authorities Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 — and if regulators agree, shots might start inside a matter of weeks.

Many dad and mom and pediatricians are clamoring for safety for children youthful than 12, at this time’s age cutoff for the vaccine made by Pfizer and its German associate BioNTech. Not solely can children generally get critically unwell, however conserving them at school is usually a problem with the coronavirus nonetheless raging in poorly vaccinated communities.

Pfizer introduced in a tweet that it had formally filed its application with the Food and Drug Administration.

UPDATE: We and @BioNTech_Group formally submitted our request to @US_FDA for Emergency Use Authorization (EUA) of our (*5*) vaccine in children 5 to

— Pfizer Inc. (@pfizer) October 7, 2021

Now the FDA could have to determine if there’s sufficient proof that the shots are secure and can work for youthful children like they do for teenagers and adults. An unbiased skilled panel will publicly debate the proof on Oct. 26.

One massive change: Pfizer says its analysis reveals the youthful youngsters ought to get a 3rd of the dose now given to everybody else. After their second dose, the 5- to 11-year-olds developed virus-fighting antibody ranges simply as robust as teenagers and younger adults get from regular-strength shots.

While youngsters are at decrease danger of extreme sickness or demise than older individuals, COVID-19 does generally kill children and circumstances in children have skyrocketed because the extra-contagious delta variant has swept via the nation

“It makes me very happy that I am helping other kids get the vaccine,” mentioned Sebastian Prybol, 8, of Raleigh, North Carolina. He is enrolled in Pfizer’s research at Duke University and does not but know if he acquired the vaccine or dummy shots.

“We do want to make sure that it is absolutely safe for them,” mentioned Sebastian’s mom, Britni Prybol. But she mentioned she can be “overjoyed” if the FDA clears the vaccine.

Pfizer studied the decrease dose in 2,268 volunteers ages 5 to 11, and has mentioned there have been no critical unintended effects. The research is not giant sufficient to detect any extraordinarily uncommon unintended effects, equivalent to the guts irritation that generally happens after the second dose of the regular-strength vaccine, principally in younger males.

If the FDA authorizes emergency use of the kid-sized doses, there’s one other hurdle earlier than vaccinations on this age group can start. Advisers to the Centers for Disease Control and Prevention will determine whether or not to advocate the shots for children, and the CDC will make a ultimate determination.

Download our Free App

For Breaking News & Analysis Download the Free CBS News app